| Kwame Appiagyei Ennin, MD | |
|
6020 W Parker Rd Ste 470, Plano, TX 75093-8338 | |
| (972) 608-8868 | |
| (972) 608-0366 |
| Full Name | Kwame Appiagyei Ennin |
|---|---|
| Gender | Male |
| Speciality | Orthopedic Surgery |
| Experience | 15 Years |
| Location | 6020 W Parker Rd Ste 470, Plano, Texas |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1194955328 | NPI | - | NPPES |
| Facility Name | Location | Facility Type |
|---|---|---|
| Home Health Professionals Dallas | Dallas, TX | Home health agency |
| Mycentric Home Health | Greenville, TX | Home health agency |
| Medical Center Of Mckinney | Mckinney, TX | Hospital |
| Medical City Plano | Plano, TX | Hospital |
| Texas Health Presbyterian Hospital Plano | Plano, TX | Hospital |
| Methodist Mckinney Hospital | Mckinney, TX | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Legacy Healthcare Services Inc | 2163339722 | 2654 |
| Texas Joint Institute, Pllc | 8325206584 | 31 |
News Archive
Regeneron Pharmaceuticals, Inc. and Bayer HealthCare today announced that Bayer HealthCare has submitted an application to the European Medicines Agency (EMA) seeking marketing authorization in the European Union (EU) for EYLEA (aflibercept) Injection for the treatment of macular edema following branch retinal vein occlusion (BRVO).
Dutch biotechnology company Crucell and the International AIDS Vaccine Initiative (IAVI) have signed an exclusive license agreement to develop an AIDS vaccine based on Crucell's AdVac® technology.
Young adults are facing tough times with limited job prospects and no health insurance. The Associated Press reports on recent college graduate Emily Weinstein as being representative of the many young uninsured Americans: "Like millions of other uninsured adults in their 20s, Weinstein is watching Congress as it advances legislation to overhaul health care.
When developing new medications, biologists and pharma- cologists test different active ingredients and chemical compounds. The main purpose is to find out how biological cells react to these substances.
› Verified 2 days ago
| Entity Name | Texas Health Physicians Group |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1174573596 PECOS PAC ID: 4385535954 Enrollment ID: O20040323000759 |
News Archive
Regeneron Pharmaceuticals, Inc. and Bayer HealthCare today announced that Bayer HealthCare has submitted an application to the European Medicines Agency (EMA) seeking marketing authorization in the European Union (EU) for EYLEA (aflibercept) Injection for the treatment of macular edema following branch retinal vein occlusion (BRVO).
Dutch biotechnology company Crucell and the International AIDS Vaccine Initiative (IAVI) have signed an exclusive license agreement to develop an AIDS vaccine based on Crucell's AdVac® technology.
Young adults are facing tough times with limited job prospects and no health insurance. The Associated Press reports on recent college graduate Emily Weinstein as being representative of the many young uninsured Americans: "Like millions of other uninsured adults in their 20s, Weinstein is watching Congress as it advances legislation to overhaul health care.
When developing new medications, biologists and pharma- cologists test different active ingredients and chemical compounds. The main purpose is to find out how biological cells react to these substances.
› Verified 2 days ago
| Entity Name | Texas Joint Institute, Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1700160744 PECOS PAC ID: 8325206584 Enrollment ID: O20120220001104 |
News Archive
Regeneron Pharmaceuticals, Inc. and Bayer HealthCare today announced that Bayer HealthCare has submitted an application to the European Medicines Agency (EMA) seeking marketing authorization in the European Union (EU) for EYLEA (aflibercept) Injection for the treatment of macular edema following branch retinal vein occlusion (BRVO).
Dutch biotechnology company Crucell and the International AIDS Vaccine Initiative (IAVI) have signed an exclusive license agreement to develop an AIDS vaccine based on Crucell's AdVac® technology.
Young adults are facing tough times with limited job prospects and no health insurance. The Associated Press reports on recent college graduate Emily Weinstein as being representative of the many young uninsured Americans: "Like millions of other uninsured adults in their 20s, Weinstein is watching Congress as it advances legislation to overhaul health care.
When developing new medications, biologists and pharma- cologists test different active ingredients and chemical compounds. The main purpose is to find out how biological cells react to these substances.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Kwame Appiagyei Ennin, MD 6020 W Parker Rd Ste 470, Plano, TX 75093-8338 Ph: (972) 608-8868 | Kwame Appiagyei Ennin, MD 6020 W Parker Rd Ste 470, Plano, TX 75093-8338 Ph: (972) 608-8868 |
News Archive
Regeneron Pharmaceuticals, Inc. and Bayer HealthCare today announced that Bayer HealthCare has submitted an application to the European Medicines Agency (EMA) seeking marketing authorization in the European Union (EU) for EYLEA (aflibercept) Injection for the treatment of macular edema following branch retinal vein occlusion (BRVO).
Dutch biotechnology company Crucell and the International AIDS Vaccine Initiative (IAVI) have signed an exclusive license agreement to develop an AIDS vaccine based on Crucell's AdVac® technology.
Young adults are facing tough times with limited job prospects and no health insurance. The Associated Press reports on recent college graduate Emily Weinstein as being representative of the many young uninsured Americans: "Like millions of other uninsured adults in their 20s, Weinstein is watching Congress as it advances legislation to overhaul health care.
When developing new medications, biologists and pharma- cologists test different active ingredients and chemical compounds. The main purpose is to find out how biological cells react to these substances.
› Verified 2 days ago
Geoffrey Glynn Glidden, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 4090 Mapleshade Ln, Plano, TX 75093 Phone: 972-608-9777 Fax: 972-403-1555 | |
Stephen P Courtney, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 1705 Ohio Dr Ste 300, Plano, TX 75093 Phone: 972-499-5457 Fax: 972-449-5342 | |
Isador H Lieberman, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 6020 W Parker Rd, Suite 200, Plano, TX 75093 Phone: 972-608-5000 | |
Dr. Matthew Aaron Prevost, MD Orthopedic Surgery Medicare: Medicare Enrolled Practice Location: 6020 W Parker Rd Ste 200, Plano, TX 75093 Phone: 972-608-5000 | |
Dr. Kendall Edward Carll Ii, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 8080 Independence Pkwy Ste 230, Plano, TX 75025 Phone: 469-998-2273 Fax: 469-998-2272 | |
Dr. Michael Patrick Markowitz, DO Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 6020 W Parker Rd Ste 200, Plano, TX 75093 Phone: 972-608-5000 | |
Dr. Jonathan Duane Ringenberg, MD Orthopedic Surgery Medicare: Medicare Enrolled Practice Location: 5228 W Plano Pkwy, Plano, TX 75093 Phone: 972-250-5700 |